Dr. Reckeweg R13 Prohämorrhin, gouttes buvables

7680450430294 CH-45043 gouttes buvables
Dr. Reckeweg R13 Prohämorrhin, gouttes buvables
Dr. Reckeweg R13 Prohämorrhin, gouttes buvables
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
50
Selling units
50
Measure
ml
Galenic form
gouttes buvables
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/02/2013
Patient information leaflet
Français
22/02/2013
Patient information leaflet
Italien
22/02/2013

Detailed composition

Substance Quantity Type Category
acidum nitricum (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
aesculus hippocastanum (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
collinsonia canadensis (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
graphites (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
hamamelis virginiana (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
nux-vomica (Ph.Eur.Hom.)
0.1 ML Substance Wirkstoff (Principe actif)
paeonia officinalis (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
sulfur (HAB)
0.1 ML Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
- Substance HBESI
aqua purificata
- Substance HNIDK

Authorization holder

Laboratoire Jacques Reboh

1744 Chénens

Authorization information

Swissmedic authorization number
45043
Drug name
Dr. Reckeweg R13 Prohämorrhin, gouttes buvables
Galenic form
TROF
Authorization status
Z
Dispensing category
D
First authorization
16/12/1987
Authorization expiration date
31/12/9999
IT Number
20.01.1.
Domain
Human medicine

Package details

Description (FR)
RECKEWEG R13 Prohämorrhin gouttes fl 50 ml
Description (DE)
RECKEWEG R13 Prohämorrhin Tropfen Fl 50 ml
Market launch
16/12/1987
Narcotic (BTM)
No
Buy us a coffee Explore the data